Goldman Sachs Group Inc.’s alternative investment arm has agreed to buy a majority stake in Dutch generic drugmaker Synthon from BC Partners.
Goldman Unit Buys €2 Billion Drugmaker Synthon From BC Partners
Estimated read time
1 min read
You May Also Like
Gazprom Expects Revenue From Gas Sales to Beat Plan This Year
December 24, 2024
American Airlines temporarily grounded flights due to technical glitch
December 24, 2024
+ There are no comments
Add yours